Introduction
Prostate cancer is one of the most common malignancies in elderly men. In 2005, more than 232,090 Americans were diagnosed with prostate cancer and more than 30,350 died of the disease (1) . In the United States, the lifetime probability of developing prostate cancer is one in six (2) .
Most prostate cancers grow slowly (3, 4) , and early detection can lead to a complete cure. However, in more than 85% of cases of prostate cancer, multiple cancer foci are found in the prostate (5) . The diagnosis of prostate cancer is based mostly on the results of ultrasonography (US)-guided transrectal biopsy. Because of the low accuracy of US for prostate cancer detection and localization, a random biopsy is usually performed instead of a targeted biopsy. However, a random biopsy has several disadvantages. For example, it may lead to an increase in complications because of the unnecessary sampling of normal prostate tissue. Moreover, cancer located outside the routine biopsy site may be missed. In addition, there may be difficulty in determining the site of a previous biopsy when repeating biopsy in a patient with a previous negative result and continuously high prostate-specific antigen levels. For these reasons, an imaging modality is needed that allows the accurate detection and localization of prostate cancer, as well as local staging, guidance of biopsy, and adequate follow-up after treatment with intensity-modulated radiation, cryosurgery, or ablation with high-intensity focused ultrasound.
Although T2-weighted MR imaging has been used widely for the pretreatment work-up of prostate cancer, the technique is limited by unsatisfactory sensitivity and specificity for cancer detection and localization. To improve the diagnostic performance of MR imaging in evaluations for prostate cancer, various other techniques have been applied. These include dynamic contrast material-enhanced MR imaging, diffusion-weighted imaging, and MR spectroscopy. The article describes the advantages and disadvantages of each of these techniques for prostate cancer detection and localization.
Anatomy of the Prostate
Approximately 70% of the prostate is composed of glandular tissue, and 30% consists of nonglandular tissue. For anatomic division of the prostate, the zonal compartment system developed by McNeal is widely accepted (6 -9) . According to this system, glandular tissue is subdivided into the central and the peripheral gland. The central gland is composed of a transitional zone and periurethral tissue, and the peripheral gland is composed of peripheral and central zones (Fig 1) . The peripheral zone includes the posterior and lateral aspects of the prostate and accounts for most of the glandular tissue (70%). It is the zone in which 70% of prostate cancers arise. The transitional zone accounts for 5% to 10% of the glandular tissue of the prostate. Cellular proliferation in the transitional zone results in benign prostatic hyperplasia. In addition, 20% of prostate cancers arise in the transitional zone.
Conventional MR Imaging
Fast spin-echo imaging with endorectal and pelvic phased-array coils is widely used for prostate cancer evaluations (10 -13) . T2-weighted fast spin-echo imaging is optimal for depicting the anatomy of the prostate. Because the prostate has uniform intermediate signal intensity at T1-weighted imaging, the zonal anatomy cannot be clearly identified on T1-weighted images. On T2-weighted images, the peripheral zone has high signal intensity, in contrast to the low signal intensity of the central and transitional zones, which consist of compactly arranged smooth muscle and loose glandular tissue (Fig 2) . The anterior fibromuscular stroma also has low signal intensity on T2-weighted images. The generally established protocol for T2-weighted imaging at our institution is as follows: repetition time msec/echo time msec, 4300/90; echo train length, 15; flip angle, 170°; field of view, 160 -200 mm; matrix size, 768 ϫ 768; section thickness, 4 mm; and intersection gap, 0 mm.
On T2-weighted images, prostate cancer in the peripheral zone appears as an area of low signal intensity that is easily differentiated from highsignal-intensity normal tissue (Fig 3) . However, The sensitivity and specificity of T2-weighted MR imaging for prostate cancer detection have varied widely. Sensitivity of 77%-91% and specificity of 27%-61% were reported for prostate cancer detection with T2-weighted imaging performed with an endorectal coil (15, 16) . Most of the previously reported data about prostate cancer detection pertain to cancer in the peripheral zone. According to the results of a study of T2-weighted imaging performed without the use of an endorectal coil, sensitivity and specificity for cancer detection were 45% and 73%, respectively (17) .
Dynamic Contrastenhanced MR Imaging
The theoretic underpinnings of this technique are based on tumor angiogenesis. In cancer, genetic mutation leads to the production and release of angiogenic factors such as the vascular permeability factor or vascular endothelial growth factor. As a result, the number of vessels increases in cancerous tissue, and the tumor vessels have greater permeability than do normal vessels, because of T2-weighted imaging has significant limitations for depicting cancer in the transitional and central zones, because cancer and normal tissues both have low signal intensity on T2-weighted images. In addition, low signal intensity may be seen in the peripheral zone on T2-weighted images in the presence of many noncancerous abnormal conditions, such as nonspecific inflammation, biopsyrelated hemorrhage, post-radiation therapy fibrosis, and changes after hormone deprivation therapy. Because of the anticoagulant effect of abundant citrate in normal tissue in the peripheral zone, blood products may persist 4 -6 weeks or longer after prostate biopsy, leading to low signal intensity on T2-weighted images (14) . Although the presence of blood products may be indicated by areas of high signal intensity on T1-weighted images, it is difficult to determine whether that finding represents cancerous tissue or only hemorrhage.
weak integrity of the vessel wall (18 -20) . Furthermore, because the amount of interstitial space is greater in cancerous tissue than in normal tissue, there is a larger gap of contrast material concentration between the plasma and the interstitial tissue. This characteristic environment makes the enhancement pattern of cancerous tissue different from that of normal tissue (21, 22) . In many experimental studies, it has been shown that the values of contrast enhancement parameters such as mean transit time, blood flow, permeability surface area, and interstitial volume are significantly greater in cancerous tissue than in normal tissue (23) (24) (25) (26) (27) . This general observation is also applicable to prostate cancer. With a fast imaging technique such as a gradient-echo sequence, the entire volume of the prostate can be imaged in a few seconds. Although a standard MR imaging protocol for dynamic contrast-enhanced MR imaging has not been completely established, there are generally accepted requirements, such as a fast imaging sequence, minimal artifacts, and high contrast resolution. At our institution, dynamic MR imaging is performed by applying a three-dimensional fast field echo sequence (17/2.9; flip angle, 20°; section thickness, 4 mm; no intersection gap; field of view, 225 mm; matrix size, 256 ϫ 192; 25 sections) in the axial plane. From the resultant imaging data, various perfusion parameters can be extracted according to the time sequence and analyzed to allow the detection and localization of prostate cancer (Figs 4, 5) (28 -30) . 2) . The x-axis shows the number of series in MR imaging, and the y-axis shows the signal intensity in arbitrary units. The onset time (a) is the time at which signal intensity began to increase. The time to peak (b) is the period between the onset time and peak enhancement. The wash-in rate (c) represents the velocity of enhancement and is defined by dϪc/bϪa, where d represents the maximum (peak) enhancement, which is defined as the absolute maximum value of enhancement. Maximum (peak) relative enhancement is defined as the difference between the absolute maximum value of enhancement and the baseline signal intensity. The washout rate is defined as the velocity of enhancement loss. The shaded area represents the area under the timesignal intensity curve for prostate cancer.
Engelbrecht et al (31) showed the usefulness of measurements of relative peak enhancement and washout rate for prostate cancer detection and localization. From their analysis of receiver operating characteristic curves, they concluded that the relative peak enhancement was the most accurate perfusion parameter for cancer detection in the peripheral zone and central region of the gland, for which the areas under the curve were, respectively, 0.93 and 0.82. Kim et al (17) demonstrated that parametric imaging of the wash-in rate was more accurate for the detection of prostate cancer in the peripheral zone than was T2-weighted imaging alone (Fig 6) . In their study, the sensitivity and specificity of peripheral zone cancer detection were 96% and 97% on parametric images of the wash-in rate but 75% and 53% on T2-weighted images (P Ͻ .05). However, they also observed significant overlap between the wash-in rate for cancer and that for normal tissue in the transitional zone. Some parameters, such as washout rate and tumor permeability, can be used for determining the effectiveness of hormone deprivation therapy as well as for the detection and localization of prostate cancer. The results of one study showed a marked reduction of tumor permeability and changes of washout pattern after androgen deprivation treatment (32) .
Dynamic contrast-enhanced MR imaging has the advantage of providing direct depiction of tumor vascularity and may obviate the use of an endorectal coil. However, the limitations of this technique include unsatisfactory depiction of transitional zone cancer in patients with hypervascular benign prostatic hyperplasia. In addition, there is as yet no consensus with regard to the best acquisition protocol and the optimal perfusion parameter for differentiating cancer from normal tissue.
Diffusion-weighted Imaging
Diffusion is the process of thermally induced random molecular displacement, or brownian motion. The diffusion properties of tissue are related to the amount of interstitial free water and permeability. In general, cancer tends to have more restricted diffusion than does normal tissue because of the high cell densities and abundance of intraand intercellular membranes in cancer (33) (34) (35) (36) (37) .
Diffusion-weighted images may be acquired with various techniques. At our institution, diffusion-weighted images are obtained by applying a gradient-echo echo-planar sequence (2700/96; flip angle, 90°; b values, 0 and 1000 sec/mm 2 ) in the axial plane. For diffusion-weighted image interpretation, images obtained with a b value of 1000 sec/mm 2 are displayed by using the reverse mode, and apparent diffusion coefficient (ADC) maps are displayed by using the conventional mode.
In prostate cancer, normal glandular architecture is disrupted and replaced by aggregated cancer cells and fibrotic stroma. These changes inhibit the movement of water macromolecules, with resultant restriction of diffusion and reduction of ADC values in the cancer tissue (Fig 7) . Despite significant differences in the mean ADC values between cancerous and normal tissues, individual variability may decrease the diagnostic accuracy of ADC measurement for prostate cancer detection and localization (38 -43) . According to the results of an analysis of receiver operating characteristic curves, the use of diffusionweighted imaging in addition to T2-weighted imaging significantly improved the accuracy of tumor detection beyond that achieved with T2-weighted imaging alone (area under the curve, 0.93 for the combined imaging techniques vs 0.87 for T2-weighted imaging alone) (44) .
At diffusion-weighted imaging, the diffusion sensitivity can be varied to control the image contrast. Traditionally, a b value of 1000 sec/mm 2 has been used because the strength of the diffusion gradients was restricted by hardware performance limitations that made it difficult to achieve acceptable echo times with higher b values. Kingsley and Monahan (45) stated that the contrast-tonoise ratio at a b value of 1000 sec/mm 2 is optimal for the detection of acute or chronic stroke; however, to our knowledge, there is no consensus regarding the optimal b value for prostate cancer detection. The use of higher b values may increase diffusion sensitivity by diminishing the hyperintensity of tissues with long T2 relaxation times (ie, T2 shine-through). However, high b values may lead to decreased absolute differences in signal intensity between cancer and normal tissue.
Diffusion-weighted imaging has advantages such as short acquisition time and high contrast resolution between tumors and normal tissue. However, this technique is limited by poor spatial resolution and the potential risk of image distortion caused by postbiopsy hemorrhage, which results in magnetic field inhomogeneity.
MR Spectroscopy
MR spectroscopy provides metabolic information about prostate tissue by demonstrating the relative concentration of chemical compounds. Normal prostate tissue contains a high level of citrate. In prostate cancer, the citrate level decreases as the citrate-producing metabolism of normal tissue is converted to a citrate-oxidating metabolism. At the same time, the level of choline in cancer is elevated because of a high turnover of phospholipid in cell membranes in the proliferating tissue. Consequently, the ratio of choline to citrate is increased in cancerous tissue. Because of the proximity of the choline and creatine peaks at MR spectroscopy performed with a 1.5-T MR unit, the ratio of choline and creatine to citrate, which also is increased in prostate cancer, is the parameter measured (Fig 8) .
Among the various MR spectroscopic sequences, the most widely used technique is threedimensional chemical shift imaging (46) with point-resolved spectroscopy, voxel excitation, and band-selective inversion with gradient dephasing for water and lipid suppression (47) . Chemical shift imaging refers to a technique that allows the acquisition of voxels in multiple sections and the display of parametric maps (of the ratio of choline Figure 8 . Biopsy-proved adenocarcinoma in a 71-year-old man. Left: MR spectrum obtained from an area of the prostate with low signal intensity at T2-weighted imaging, in which cancer was pathologically proved, demonstrates an elevated ratio (in arbitrary units) of choline (Ch) and creatine (Cr) to citrate (Ci). Right: MR spectrum obtained from an area with normal signal intensity shows a spectral pattern with citrate dominance and no abnormal elevation of choline and creatine. and creatine to citrate) in correlation with T2-weighted morphologic images.
According to Kurhanewicz et al (48) , peripheral-zone voxels in which the ratio of choline and creatine to citrate is at least 2 standard deviations above the average ratio are considered to represent possible cancer. Voxels are considered very suggestive of cancer if the ratio of choline and creatine to citrate is more than 3 standard deviations above the average ratio (49) . However, no consensus has been reached about the metabolite ratio that can exactly determine the presence of prostate cancer, and there may be individual variability in spectral analysis among patients. Furthermore, a voxel may contain nondiagnostic levels of metabolites or may be affected by an artifact that obscures the metabolite frequency range.
The combined use of MR spectroscopy and MR imaging has been shown to improve cancer detection and localization in the peripheral zone (16) and cancer volume measurement in the peripheral zone (50). Scheidler et al (16) demonstrated a sensitivity and specificity for cancer detection of 91% and 95% for combined MR spectroscopy and MR imaging, but 77%-81% and 46%-61% for MR imaging alone and 63% and 75% for MR spectroscopy alone. Furthermore, on the basis of a strong correlation between the volume of prostate cancer and its extracapsular extension (51) (52) (53) , investigators have shown that the combination of volumetric data from MR spectroscopy and T2-weighted imaging may result in improved accuracy in determining extracapsular tumor extension (54) .
In recent years, other merits of MR spectroscopy have been noted. The results of several studies show that prostate biopsy directed with endorectal MR spectroscopy may help increase the cancer detection rate in patients with an elevated prostate-specific antigen level and a previous negative biopsy result (55) (Fig 9) . In addition, investigators have observed a trend toward an increasing ratio of choline and creatine to citrate in association with an increasing Gleason score, a trend suggestive of the potential usefulness of MR spectroscopy for noninvasive estimation of cancer aggressiveness (56) .
MR spectroscopy also is more useful than conventional MR imaging for detecting transitional zone cancer (Fig 10) . However, the cancer metabolite ratio in the transitional zone varies broadly, and thus there may be overlap in me- tabolite ratios between cancerous and benign tissues in the transitional zone (57) .
MR spectroscopy is useful, in addition, for planning treatment and determining therapeutic effectiveness, as well as for detecting a recurrent tumor after surgery, radiation therapy, or hormone deprivation therapy. The ratio of choline and creatine to citrate is indicative of the tumor response to treatment (58 -61) .
The advantages of MR spectroscopy are its generally accepted accuracy, its capability for depicting possible cancer in the transitional zone, and its widely proved diagnostic performance. However, the technique is disadvantaged by long acquisition time, possible variability in results dependent on postprocessing or shimming, and no direct visualization of the periprostatic anatomy.
Furthermore, a previous prostate biopsy may lead to spectral degradation that makes accurate interpretation of the metabolite ratios impossible. According to the results of a previous study, the mean percentage of degraded peripheral-zone voxels was 19% at MR spectroscopy performed within 8 weeks after biopsy, compared with 7% after 8 weeks (62) . An adequate time interval is necessary between prostatic biopsy and MR examination. In another study, investigators showed that, despite the potential risk of hemorrhage, MR spectroscopy may improve the ability to determine the presence of prostate cancer and its spatial extent when postbiopsy changes hinder interpretation with the use of conventional MR images alone (63) . 
Conclusions
Various MR imaging techniques beyond conventional T2-weighted imaging can provide improved cancer detection and localization, as well as information regarding the biologic behavior, volume, and staging of cancers for individualized therapy. However, each technique has one or more limitations, such as no standard parameters, or low accuracy in the central region of the gland. No randomized large study has been performed to compare the techniques, and there has been no report with regard to which technique is best in a specific clinical situation. Furthermore, the existing literature contains little information about the effectiveness of MR imaging at 3.0 T for the evaluation of prostate cancer. Therefore, a comprehensive understanding of the advantages and disadvantages of various MR imaging techniques and protocols is expected to improve the MRbased detection and localization of prostate cancer (Figs 11, 12 ). 
